Working With CRT

Testimonials
Licensing Opportunities

Small Molecules

Biological Therapeutics

New Targets

Diagnostics

Enabling Technology

Antibody Catalogue

Register

Privileged Access Section
CRT's Development Pipeline
Commercialisation Routes

Anti-Rad24 Polyclonal
Antigen: Rad24
Relevance:
Rad24 is a component of the DNA damage-dependent checkpoint pathway in yeast
Applications: Western blot
Immunogen: Recombinant Rad24 fragment
Reactivity: Yeast (S.cerevisiae)
Species raised in: Rabbit
References: Green CM et al. 2000. Curr. Biol. 10(1):39-42 PubMed Logo
Notes: Suggested dilution for western blot: 1/3,000

For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Click here to view Notes and Disclaimer information

[back]
Contact Us | Terms & Conditions | Site Map | Search | Downloads